Veradigm | MDRX - Operating Expenses


Veradigm reported $188M in Operating Expenses for its fiscal quarter ending in December of 2022.





Operating Expenses Change Date
Alcidion AUD 23.27M 565K Dec/2025
Ambu A/S DKK 1.4B 6M Mar/2026
Amplifon EUR 600.86M 61.82M Dec/2025
Cardinal Health USD -2.83B 52M Mar/2026
Centene USD 21.43B 29.53B Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cigna USD 42.21B 497.12M Mar/2026
Coloplast 5.19B 185M Dec/2025
Computer Programs Systems USD 207.2M 119.28M Dec/2025
Convatec Group USD 1B 518M Dec/2024
CVS Health USD 95.75B 7.84B Mar/2026
Diasorin EUR 231M 511K Mar/2026
Elevance Health USD 43.9B 5.26B Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Gulf Medical Proj AED 182.97M 16.46M Dec/2025
Humana USD 37.89B 4.57B Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Laboratory Of America USD 3.13B 6.3M Mar/2026
Maximus USD 1.7B 22.85M Mar/2026
McKesson USD 94.46B 10.04B Mar/2026
Med Life RON 747.87M 6.92M Sep/2025
Molina Healthcare USD 4.08B 7.45B Mar/2026
Omnicell USD 292.84M 19.96M Mar/2026
Oriola-kd EUR 496.6M 39.9M Dec/2025
Owens Minor USD -464.76M 1.17B Mar/2026
Quest Diagnostics USD 2.5B 76M Mar/2026
Rede D'or Sao Luiz BRL 11.43B 385.31M Mar/2026
Siemens Healthineers EUR 4.95B 229M Mar/2026
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 250.99M 97.72M Dec/2025
UnitedHealth USD 102.68B 7.27B Mar/2026
Veeva Systems USD 590.07M 19.69M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Xerox USD 299M 145M Mar/2026